NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 10 filers reported holding NLS PHARMACEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 827,921 | $2,069,000 | 0.44% |
| Worth Venture Partners, LLC | 194,560 | $161,000 | 0.07% |
| ARMISTICE CAPITAL, LLC | 500,000 | $413,000 | 0.01% |
| Warberg Asset Management LLC | 35,480 | $29,000 | 0.01% |
| Hudson Bay Capital Management LP | 200,000 | $154,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,635 | $2,000 | 0.00% |
| Bank Julius Baer & Co. Ltd, Zurich | 7,370 | $6,000 | 0.00% |